[go: up one dir, main page]

BG103947A - Derivatives of 9-oxymerythromycin - Google Patents

Derivatives of 9-oxymerythromycin

Info

Publication number
BG103947A
BG103947A BG103947A BG10394799A BG103947A BG 103947 A BG103947 A BG 103947A BG 103947 A BG103947 A BG 103947A BG 10394799 A BG10394799 A BG 10394799A BG 103947 A BG103947 A BG 103947A
Authority
BG
Bulgaria
Prior art keywords
oxymerythromycin
derivatives
compounds
methods
relates
Prior art date
Application number
BG103947A
Other languages
Bulgarian (bg)
English (en)
Inventor
Yong- Jin WU
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of BG103947A publication Critical patent/BG103947A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BG103947A 1997-06-11 1999-12-03 Derivatives of 9-oxymerythromycin BG103947A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11
PCT/IB1998/000741 WO1998056800A1 (en) 1997-06-11 1998-05-15 9-oxime erythromycin derivatives

Publications (1)

Publication Number Publication Date
BG103947A true BG103947A (en) 2000-07-31

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103947A BG103947A (en) 1997-06-11 1999-12-03 Derivatives of 9-oxymerythromycin

Country Status (31)

Country Link
EP (1) EP0988308A1 (xx)
JP (1) JP2000513026A (xx)
KR (1) KR20010013660A (xx)
CN (1) CN1259135A (xx)
AP (1) AP9801253A0 (xx)
AR (1) AR012244A1 (xx)
AU (1) AU7226798A (xx)
BG (1) BG103947A (xx)
BR (1) BR9810021A (xx)
CA (1) CA2293335A1 (xx)
CO (1) CO4940506A1 (xx)
CZ (1) CZ9904388A3 (xx)
EA (1) EA199901016A1 (xx)
GT (1) GT199800074A (xx)
HN (1) HN1998000073A (xx)
HR (1) HRP980316A2 (xx)
HU (1) HUP0002252A3 (xx)
ID (1) ID24529A (xx)
IL (1) IL132767A0 (xx)
IS (1) IS5251A (xx)
MA (1) MA26505A1 (xx)
NO (1) NO996108L (xx)
OA (1) OA11225A (xx)
PA (1) PA8451801A1 (xx)
PE (1) PE79899A1 (xx)
PL (1) PL337606A1 (xx)
TN (1) TNSN98083A1 (xx)
TR (1) TR199902995T2 (xx)
TW (1) TW448174B (xx)
WO (1) WO1998056800A1 (xx)
ZA (1) ZA985018B (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
AU5299499A (en) * 1998-09-22 2000-04-10 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
ES2272273T3 (es) * 1999-04-16 2007-05-01 Kosan Biosciences, Inc. Agentes antiinfecciosos macrolidos.
CZ20013733A3 (cs) 1999-05-24 2002-11-13 Pfizer Products Inc. Deriváty 13-methylerythromycinu
DE60005334T2 (de) * 1999-06-07 2004-06-24 Abbott Laboratories, Abbott Park 6-o-carbamat ketolide derivate
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
CA2529817C (en) * 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
JP5383037B2 (ja) 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
CN102223794B (zh) 2008-10-24 2017-12-22 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
CN102146085B (zh) * 2010-02-09 2014-03-26 北京理工大学 一种9-肟醚酮内酯衍生物、制备方法及其药物组合物
BR112012023950A2 (pt) 2010-03-22 2016-07-05 Cempra Pharmaceuticals Inc formas cristalinas de um macrolídeo, e usos dos mesmos
ES2636948T3 (es) 2010-05-20 2017-10-10 Cempra Pharmaceuticals, Inc. Procesos para preparar macrólidos y cetólidos e intermediarios para los mismos
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc FLUOROCETOLIDES FORMING HYDROGEN LINKS TO TREAT DISEASES
RU2658050C2 (ru) 2012-03-27 2018-06-19 Семпра Фармасьютикалз, Инк. Парентеральные составы для введения макролидных антибиотиков
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
RU2015138797A (ru) 2013-03-15 2017-04-24 Семпра Фармасьютикалс, Инк. Конвергентные способы получения макролидных антибактериальных агентов

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
GT199800074A (es) 1999-11-27
BR9810021A (pt) 2000-09-19
TNSN98083A1 (fr) 2005-03-15
TW448174B (en) 2001-08-01
CN1259135A (zh) 2000-07-05
EP0988308A1 (en) 2000-03-29
PL337606A1 (en) 2000-08-28
ZA985018B (en) 1999-12-10
EA199901016A1 (ru) 2000-06-26
NO996108L (no) 2000-02-10
AP9801253A0 (en) 1999-12-04
AR012244A1 (es) 2000-09-27
HN1998000073A (es) 1999-01-08
CO4940506A1 (es) 2000-07-24
WO1998056800A1 (en) 1998-12-17
ID24529A (id) 2000-07-20
PA8451801A1 (es) 2000-05-24
NO996108D0 (no) 1999-12-10
OA11225A (en) 2003-07-17
HUP0002252A2 (hu) 2000-12-28
HRP980316A2 (en) 1999-04-30
IL132767A0 (en) 2001-03-19
AU7226798A (en) 1998-12-30
JP2000513026A (ja) 2000-10-03
IS5251A (is) 1999-11-16
TR199902995T2 (xx) 2000-02-21
CZ9904388A3 (cs) 2002-10-16
MA26505A1 (fr) 2004-12-20
KR20010013660A (ko) 2001-02-26
CA2293335A1 (en) 1998-12-17
PE79899A1 (es) 1999-08-25
HUP0002252A3 (en) 2002-01-28

Similar Documents

Publication Publication Date Title
BG103947A (en) Derivatives of 9-oxymerythromycin
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
BG103417A (en) Condensed pyrimidine bicyclic derivatives
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
BG100946A (en) New amino acid derivatives, method for their preparation and pharmaceutical compositions containing them
MY115662A (en) Novel compounds with analgesic effect
BG103969A (en) C-4"-substituted macrolide derivatives
AP9701019A0 (en) Phenylamino-substituted tricycle derivatives.
BG103518A (en) 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
BG101110A (en) Substituted pyrimidine compounds and their application
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
MY122353A (en) 13-membered azalides and their use as antibiotic agents
BG100069A (en) Amidine derivatives containing heterocylic groups, their preparation and application
MY115211A (en) Novel amino acid derivatives, their preparation and use
CA2286511A1 (en) Novel macrolide derivatives
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
AP9801377A0 (en) Tricyclic erythromycin derivatives.
IL110460A0 (en) Bis-naphthalimides and pharmaceutical compositions containing them
AU2566101A (en) Compounds and methods for the treatment of pain
WO2001005386A3 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
AP9801235A0 (en) Erythromycin derivatives.
YU46302A (sh) Supstituisani piroli
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use